Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
基本信息
- 批准号:9976617
- 负责人:
- 金额:$ 12.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute DiseaseAdaptive Immune SystemAdvisory CommitteesAffectAgeAlphavirusAlphavirus InfectionsAmericasAnimal ModelArbovirusesArthritisArthritogenicAutopsyAwardB-LymphocytesC57BL/6 MouseCaribbean regionCentral Nervous System InfectionsCessation of lifeChikungunya virusChildClinicalCulicidaeDataDevelopmentDiseaseDisease OutcomeDoctor of PhilosophyEmotionalEncephalitisEncephalomyelitisExanthemaFlavivirusFoundationsFundingFutureGeneticGenetic VariationGeographyHumanImmuneImmune responseImmune systemImmunologyIndividualInfantInfectionInflammatory ResponseKnowledgeLeftMaus Elberfeld virusMediatingMedicineMeningitisMentorsMentorshipModelingMouse StrainsMusMyositisNervous System TraumaNeuraxisNeurologicNeurologic DeficitNeurological ModelsNeuronsNeuropathogenesisNorth CarolinaOutcomePathogenesisPathologyPathway interactionsPatientsPeripheralPhylogenetic AnalysisPlayPopulationPredispositionPublic HealthResearchResearch PersonnelResearch TrainingRoleSeizuresSeveritiesSeverity of illnessSindbis VirusSolidSupportive careSystemic diseaseT-LymphocyteTestingTherapeuticTimeTissue SampleTrainingTranslational ResearchUniversitiesVaccinesVariantVeterinariansViralViral PathogenesisVirusVirus DiseasesVirus Replicationbasecareerchikungunya infectioncollaborative environmentcomparativedisabilitydoctoral studentexperiencegenetic strainhuman diseaseinfectious disease modelmouse geneticsmouse modelnervous system disorderneuropathologyneurovirulencenovelprofessorprogramsskillstargeted treatmentvirus genetics
项目摘要
Abstract
The purpose of this K01 SERCA application is to provide the protected research time and mentorship
necessary for Dr. Victoria Baxter, DVM, PhD, DACLAM to make the transition to independent investigator. Dr.
Baxter is a veterinarian with a strong background in comparative medicine, viral immunology, and animal
models of infectious disease, making her uniquely qualified for a career in translational research. Under the
guidance of her mentor Dr. Mark Heise and an experienced interdisciplinary advisory committee, the training
and aims outlined in this proposal will allow Dr. Baxter to expand her knowledge in viral and host genetics in
order to establish a solid foundation for her own independent research program focused on understanding the
pathogenesis of emerging and re-emerging viral diseases. The University of North Carolina at Chapel Hill will
provide the interactive and collaborative environment necessary to support her transition to independence.
Encephalitic arboviruses represent a re-emerging cause of human disease and disability, as patients who
survive the initial acute disease are often left with lifelong neurological deficits. While chikungunya virus
(CHIKV), an alphavirus that has recently spread to the Americas and Caribbean, typically causes a systemic
disease characterized by rash and arthritis, individuals frequently develop neurological complications. Very
little has been done to examine CHIKV encephalomyelitis, as no reliable small animal model currently exists.
Most of the knowledge regarding the pathogenesis of alphavirus infection of the central nervous system (CNS)
comes from the well-characterized mouse model of alphavirus encephalomyelitis using Sindbis virus. Outcome
of CNS infection by Sindbis virus is dependent on both viral and mouse strain genetics, and CNS damage is
primarily mediated by the immune response. This suggests three independent but interrelated factors drive
CHIKV encephalomyelitis: viral genetics, host genetics, and the host immune system. The central hypothesis
of the proposed studies is that CHIKV encephalomyelitis develops due to a combination of viral and host
genetic factors, resulting in CNS damage that is primarily mediated by the host immune response rather than
directly by CHIKV. This hypothesis will be tested with the following specific aims:
Specific Aim #1: Determine if CHIKV genetic variation confers neurovirulence in a mouse model of CHIKV
encephalomyelitis.
Specific Aim #2: Elucidate the contribution of the adaptive immune system to CHIKV encephalomyelitis.
Specific Aim #3: Determine if host genetic variation impacts susceptibility to CHIKV encephalomyelitis.
These studies will generate valuable data that will provide a foundation for a future R01 application aimed at
further elucidating mechanisms of CHIKV neuropathogenesis, and SERCA funding will provide Dr. Baxter with
the skills necessary to establish similar models for examining other emerging viral diseases in the future.
抽象的
此 K01 SERCA 申请的目的是提供受保护的研究时间和指导
Victoria Baxter 博士(DVM、PhD、DACLAM)过渡为独立研究者所必需的。博士。
Baxter 是一位兽医,在比较医学、病毒免疫学和动物学方面拥有深厚的背景
传染病模型,使她具有从事转化研究职业的独特资格。下
在她的导师 Mark Heise 博士和经验丰富的跨学科咨询委员会的指导下,培训
该提案中概述的目标将使巴克斯特博士能够扩展她在病毒和宿主遗传学方面的知识
为了为她自己的独立研究计划奠定坚实的基础,重点是了解
新出现和重新出现的病毒性疾病的发病机制。北卡罗来纳大学教堂山分校将
提供支持她向独立过渡所需的互动和协作环境。
脑炎虫媒病毒是人类疾病和残疾的重新出现的原因,因为患者
在最初的急性疾病中幸存下来的人通常会留下终生的神经功能缺陷。虽然基孔肯雅病毒
(CHIKV)是一种最近传播到美洲和加勒比地区的甲病毒,通常会引起系统性感染
以皮疹和关节炎为特征的疾病,个体经常出现神经系统并发症。非常
由于目前不存在可靠的小动物模型,因此在检查 CHIKV 脑脊髓炎方面做得很少。
大多数关于中枢神经系统(CNS)甲病毒感染发病机制的知识
来自使用辛德比斯病毒的甲病毒脑脊髓炎小鼠模型。结果
辛德比斯病毒感染中枢神经系统的程度取决于病毒和小鼠品系的遗传学,中枢神经系统损伤是
主要由免疫反应介导。这表明三个独立但相互关联的因素驱动
CHIKV 脑脊髓炎:病毒遗传学、宿主遗传学和宿主免疫系统。中心假设
拟议研究的其中一个内容是,CHIKV 脑脊髓炎是由于病毒和宿主的共同作用而发生的
遗传因素,导致中枢神经系统损伤,主要是由宿主免疫反应介导的,而不是
直接由 CHIKV 提供。该假设将通过以下具体目标进行检验:
具体目标 #1:确定 CHIKV 遗传变异是否赋予 CHIKV 小鼠模型神经毒力
脑脊髓炎。
具体目标#2:阐明适应性免疫系统对 CHIKV 脑脊髓炎的影响。
具体目标#3:确定宿主遗传变异是否影响对 CHIKV 脑脊髓炎的易感性。
这些研究将产生有价值的数据,为未来的 R01 应用奠定基础
进一步阐明 CHIKV 神经发病机制,SERCA 资助将为 Baxter 博士提供
建立类似模型以检查未来其他新出现的病毒性疾病所需的技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VICTORIA K BAXTER其他文献
VICTORIA K BAXTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VICTORIA K BAXTER', 18)}}的其他基金
Modeling chikungunya virus neuroinvasion and neuropathogenesis in mice
基孔肯雅病毒神经侵袭和小鼠神经发病机制的建模
- 批准号:
10790337 - 财政年份:2023
- 资助金额:
$ 12.62万 - 项目类别:
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
- 批准号:
10764851 - 财政年份:2023
- 资助金额:
$ 12.62万 - 项目类别:
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
- 批准号:
10454121 - 财政年份:2018
- 资助金额:
$ 12.62万 - 项目类别:
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
- 批准号:
10216374 - 财政年份:2018
- 资助金额:
$ 12.62万 - 项目类别:
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
中枢神经系统基孔肯雅病毒感染的发病机制和宿主反应
- 批准号:
9582368 - 财政年份:2018
- 资助金额:
$ 12.62万 - 项目类别:
相似国自然基金
转录因子LeuO激活适应性免疫系统CRISPR/Cas防御大肠杆菌自然转化的机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
适应性免疫系统的发育和应答
- 批准号:
- 批准年份:2020
- 资助金额:400 万元
- 项目类别:国家杰出青年科学基金
不同年龄牦牛免疫系统发育特征及其对高原环境的适应机制
- 批准号:31572478
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
肠道共生细菌与七鳃鳗可变淋巴细胞受体VLRA、VLRC交联对话( Cross-talk)机制研究
- 批准号:31500106
- 批准年份:2015
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Galectin-3 对调节移植物抗宿主病 (GvHD) 和移植物抗肿瘤 (GVT) 反应的影响
- 批准号:
10598800 - 财政年份:2022
- 资助金额:
$ 12.62万 - 项目类别:
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Galectin-3 对调节移植物抗宿主病 (GvHD) 和移植物抗肿瘤 (GVT) 反应的影响
- 批准号:
10619457 - 财政年份:2022
- 资助金额:
$ 12.62万 - 项目类别:
Innate Control of Adaptive Immunity to SARS-CoV-2
对 SARS-CoV-2 的适应性免疫的先天控制
- 批准号:
10284699 - 财政年份:2021
- 资助金额:
$ 12.62万 - 项目类别:
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GvT) Responses
Galectin-3 对调节移植物抗宿主病 (GvHD) 和移植物抗肿瘤 (GvT) 反应的影响
- 批准号:
10362542 - 财政年份:2021
- 资助金额:
$ 12.62万 - 项目类别:
Innate Control of Adaptive Immunity to SARS-CoV-2
对 SARS-CoV-2 的适应性免疫的先天控制
- 批准号:
10407641 - 财政年份:2021
- 资助金额:
$ 12.62万 - 项目类别: